Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine
Authors:
- Pi-Che ChenPCPi-Che Chen
- Ming-Hsuan TsaiMTMing-Hsuan Tsai
- Sidney Kh YipSYSidney Kh Yip
- Yeong-Chin JouYJYeong-Chin Jou
- Chi-Fai NgCNChi-Fai Ng
- Yanning ChenYCYanning Chen
- Wei HuangWHWei Huang
- Chun-Liang TungCTChun-Liang Tung
- Gary Cw ChenGCGary Cw Chen
- Martin Ms HuangMHMartin Ms Huang
- Joanna Hm TongJTJoanna Hm Tong
Open Access
- 20 May 2011
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 4 (1) , 45
Abstract
Background: Bladder cancer is the sixth most common cancer in the world and the incidence is particularly high in southwestern Taiwan. Previous studies have identified several tumor-related genes that are hypermethylated in bladder cancer; however the DNA methylation profile of bladder cancer in Taiwan is not fully understood. Methods: In this study, we compared the DNA methylation profile of multiple tumor suppressor genes (APC, DAPK, E-cadherin, hMLH1, IRF8, p14, p15, RASSF1A, SFRP1 and SOCS-1) in bladder cancer patients from different Chinese sub-populations including Taiwan (104 cases), Hong Kong (82 cases) and China (24 cases) by MSP. Two normal human urothelium were also included as control. To investigate the diagnostic potential of using DNA methylation in non-invasive detection of bladder cancer, degree of methylation of DAPK, IRF8, p14, RASSF1A and SFRP1 was also accessed by quantitative MSP in urine samples from thirty bladder cancer patients and nineteen non-cancer controls. Results: There were distinct DNA methylation epigenotypes among the different sub-populations. Further, samples from Taiwan and China demonstrated a bimodal distribution suggesting that CpG island methylator phentotype (CIMP) is presented in bladder cancer. Moreover, the number of methylated genes in samples from Taiwan and Hong Kong were significantly correlated with histological grade (P < 0.01) and pathological stage (P < 0.01). Regarding the samples from Taiwan, methylation of SFRP1, IRF8, APC and RASSF1A were significantly associated with increased tumor grade, stage. Methylation of RASSF1A was associated with tumor recurrence. Patients with methylation of APC or RASSF1A were also significantly associated with shorter recurrence-free survival. For methylation detection in voided urine samples of cancer patients, the sensitivity and specificity of using any of the methylated genes (IRF8, p14 or sFRP1) by qMSP was 86.7% and 94.7%. Conclusions: Our results indicate that there are distinct methylation epigenotypes among different Chinese sub-populations. These profiles demonstrate gradual increases with cancer progression. Finally, detection of gene methylation in voided urine with these distinct DNA methylation markers is more sensitive than urine cytology.Keywords
This publication has 44 references indexed in Scilit:
- Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resectionUrologic Oncology: Seminars and Original Investigations, 2012
- Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cellsToxicology and Applied Pharmacology, 2010
- Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancerLaboratory Investigation, 2010
- CpG Methylation of a Silent Controlling Element in the Murine Avy Allele Is Incomplete and Unresponsive to Methyl Donor SupplementationPLOS ONE, 2010
- The Epigenomics of CancerCell, 2007
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patientsInternational Journal of Cancer, 2003
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000